Andreas L.
- Country
- Germany
- Department
- Campus Benjamin Franklin
Research Overview
- Long-term Evaluation of Safety, Tolerability, and Efficacy of AL002 and Florquinitau (18F) in Patients with Alzheimer's Disease
- Efficacy and Safety Evaluation of Mirodenafil Dihydrochloride in Early Alzheimer's Disease: A Phase 3 Double-Blind, Randomized, Placebo-Controlled Trial
- Evaluation of RO7269162 on Amyloid Biomarkers in Prodromal Alzheimer's Disease: A Phase IIa Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 90 of 153 partner sites.
Specializations
Neurodegenerative Disorders
This investigator specializes in the study of Alzheimer's Disease, with particular emphasis on early-stage and mild manifestations of the condition. Their research encompasses therapeutic interventions for cognitive decline and dementia-related symptoms.
- Early-stage Alzheimer's Disease
- Mild Cognitive Impairment
- Prodromal Alzheimer's Disease
The investigator focuses on evaluating novel therapeutic approaches for managing cognitive decline progression.
Clinical Assessment
Expertise in utilizing clinical assessment tools and evaluation methods, particularly the Clinical Dementia Rating Scale. The investigator's work involves comprehensive monitoring of disease progression and treatment responses.
- Cognitive Function Assessment
- Disease Progression Monitoring
- Treatment Response Evaluation
Their research incorporates long-term safety and efficacy assessments of therapeutic interventions.
Therapeutic Development
The investigator's research includes evaluation of novel therapeutic compounds and their effects on disease mechanisms. Their work encompasses both pharmacological efficacy and safety assessments.
- Drug Safety Evaluation
- Treatment Tolerability
- Therapeutic Response Analysis
The focus includes investigation of innovative treatment approaches for neurodegenerative conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.